Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Entinostat|DRUG: Atezolizumab|DRUG: Placebo
Sponsor: Syndax Pharmaceuticals
Collaborators: Roche Pharma AG